Table 3.
Influence of Lumefantrine Plasma Concentration Below Cut-off Values on Treatment Outcome in SSA Populations
| Study | Country | Study Population | Plasma Concentration/Cut-Off Values | Study End Points | Treatment Outcome (study end points) | Reference |
|---|---|---|---|---|---|---|
| Kilonzi et al | Tanzania | Children | 200ng/µL | ACPR | Was not different between those with low and above cut-off values | [56] |
| Bell et al | Malawi | 175ng/µL | ACPR | Was not different between those with low and above cut-off values | [57] | |
| Marwa et al | Tanzania | Children and adults | 175&200ng/µL | ACPR | Was not different between those with low and above cut-off values | [58] |
| Checchi et al | Uganda | Children and adults | 280ng/µL | Recrudescence | Was not different between those with low and above cut-off values | [59] |
| Ippolito et al | Zambia | Children | 280ng/µL | Re-infection | No difference between patients with low and above cut-off values | [60] |